ArticlePloS one2026
A human 3D BBB chip model of acute stroke simulating a reversible penumbra.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic stroke is a leading cause of mortality and disability worldwide. However, existing models often fail to replicate key aspects of human pathophysiology, particularly blood-brain barrier (BBB) dysfunction and the salvageable ischemic penumbra. We developed a three-dimensional BBB chip model of acute ischemic stroke that reproduces penumbra-like, partially reversible BBB injury. This platform integrates a microfluidic BBB chip (Emulate) with parallel Transwell inserts to facilitate complementary structural, molecular, and functional analyses. Ischemia-like injury was induced using 2.5 μM antimycin A for 1 hour under oxygen-glucose deprivation conditions, followed by medium replacement to simulate reperfusion. Therapeutic hypothermia (33°C) was also applied during the reperfusion phase. The combination of reperfusion and hypothermia resulted in the most pronounced restoration of BBB integrity compared with reperfusion alone. The Emulate chip enabled structural evaluation of endothelial morphology, while the transwell model showed concordant recovery of BBB-related markers, including ZO-1 and VE-cadherin, along with decreased expression of the hypoxia-associated marker HIF-1α. This integrated platform enabled evaluation of BBB injury and recovery under ischemia- and reperfusion-like conditions. Our human cell-based 3D BBB stroke model captures key BBB-related features of penumbra-like injury and provides a human-relevant in vitro platform for investigating stroke pathophysiology and evaluating therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.